Searched for
ABHAY SHANBHAG
- Ranbaxy and Dr Reddy's to take a hit as Lipitor market shrinks 96%
Analysts expect prices of atorvastatin, generic version of Lipitor, to drop further as additional players enter the market.
- Ranbaxy falls 7% to nine-month low on USFDA settlement costs
Analysts said Ranbaxy could lose millions of dollars in potential revenues and undergo a time consuming process before it resume supplies
- Pfizer marketing may hit Ranbaxy’s profit from low-cost lipitor version
Late last year, Pfizer started offering ‘co-pay’ programmes which lowered out of pocket payment by insured patients to $4 a month for a Lip...
- USFDA bans sale of medicines from DRL's Mexico facility, warns Cadila
The USFDA on Wednesday banned the US sale of medicines made at Dr Reddy's Mexican facility and sent a warning to letter Cadila Healthcare f...
- Ranbaxy shares fall by 8.7% after report of $1 billion US FDA fine
The proposed penalty on Ranbaxy reported by Fortune magazine is more than double of what the industry has been speculating.
- Good time to buy infra stocks, not funds
Infrastructure stocks are available at very low valuations and can be good long-term buys. Taking the mutual fund route may not be that pro...